TFPI and hemorrhagic disease: On the other hand, suppressor mechanisms are known to regulate coagulation, with AT and TFPI acting as two of the important inhibitors of coagulation in this feedback process; therefore, approaches that inhibit AT or TFPI are also expected to achieve hemostatic activity in bleeding disorders.